Answers are grounded in this paper and cite their sources.
In vitro experimental study demonstrates antimicrobial activity of novel thiazolo[3,2-a] pyrimidines against bacteria and fungi, highlighting potential new anti-infective leads.
New compound 6-Cyano-3-(4-cyanophenyl)-7-(methylthio)-5-oxo-5H-thiazolo[3,2-a] pyrimidine (3) was synthesized in this study by refluxing the ethyl 2-cyano-3,3-bis(methylthio)acrylate and 4-(2-aminothiazol-4-yl) benzonitrile in anhydrous K₂CO₃ and DMF solvent. IR, ¹H NMR, and mass spectrometry were used to confirm the structure of the new compound. Antibacterial and antifungal activity of derivatives studied by using different bacteria and fungi. Out of all derivatives, compounds 3a and 3c have antimicrobial potential. The synthesized compounds were evaluated for lipophilicity and ADME properties by log P and in silico ADME estimation.
No takes yet. Share an insight, caveat, or question.
Auti et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: